POTS and Sleep: Why Rest Doesn’t Come Easily, And What Actually Helps

Tired man slumped on a desk with glasses removed, unable to sleep with POTS
Adam Foster

This article is part of our comprehensive guide to POTS and dysautonomia.

Sleep in POTS is genuinely worse than it is for people without it, and that turns up consistently on every decent questionnaire anybody has handed out [1][2][3]. What it mostly doesn’t turn up as though, is a separate hidden sleep disorder sitting quietly underneath the POTS with its own name and its own treatment pathway. That’s the awkward gap in all of this, as when people with POTS are wired up for a night and measured properly, the results tend to come back a great deal closer to normal than the nights actually feel [4][5][6]. Which is how you end up being told your sleep is “fine”, on paper, while lying there at four in the morning with a heart rate that has plans of its own.

The most sensible reading of the evidence at the moment is that the problem at night in POTS is arousal rather than architecture. The stages are roughly where they should be, more or less, but the nervous system never really stands down, and a body that has spent all day compensating for a circulation that doesn’t behave itself, doesn’t switch that compensation off just because the light went out [4][6][7].

So, this article goes through what’s actually known: how bad the sleep problem is, why overnight testing keeps coming back unremarkable, what the autonomic side of it looks like, where sleep apnoea really does and really doesn’t fit, and what the evidence supports doing about any of it. Some of it is solid, a lot of it is thin, and where it’s thin we’ll say so, because the alternative is another article telling you to have a warm bath and put your phone away.

How Bad the Sleep Actually Is

Ask people with POTS about their sleep using the questionnaires designed for the job and the answers come back worse than the comparison groups on pretty much everything that matters: how much the sleep problem interferes with daily life, how sleepy they are during the day, and how tired they are full stop [1][2][3]. That’s not one group in one city having a bad month either, it holds across separate groups in separate countries, which is about as consistent as this field ever gets.

The complaints themselves are fairly stereotyped and they’ll probably be familiar: sleep that doesn’t refresh you regardless of how many hours it lasted, difficulty getting off in the first place, waking in the night, and waking far too early with no route back [4][3]. Daytime sleepiness severe enough to count as excessive on the standard scale turns up in around half of those with POTS, against something like one in six of people without it [1].

Sleepiness and fatigue get measured separately in this work, by the way, and both come back worse [1][2][3]. That’s worth a moment, as they’re not the same thing and the distinction is genuinely useful in a consultation. Sleepiness is the pull towards actually falling asleep, the head nodding in a warm room, the inability to stay awake through a film. Fatigue is the flat battery, where sleep isn’t available and wouldn’t help much if it were. Plenty of people with POTS have both, and plenty have the second without much of the first, which is why being told to have an early night can feel so far off the point. If you can describe which one you’ve got, and ideally which one is worse, you’ll get a more sensible conversation than if you go in with the word tired, which means about six different things depending on who’s listening.

Now, you’ll have seen bigger numbers than that quoted online. There’s an online survey doing the rounds where nearly everybody screened as a poor sleeper [8]. Take that one gently though, as it was entirely self reported and recruited through channels that pull in the people doing worst, so it tells you a great deal about who fills in sleep surveys and rather less about the average person with POTS. The questionnaire work with proper comparison groups is the sturdier evidence, and it says much the same thing in a less dramatic voice.

Poor sleep also tracks with worse quality of life and a heavier overall symptom load [1][9][10]. That one needs a caveat though, as almost all of it is observational, meaning these things were measured in the same people at the same time and found to move together, and nobody has shown which way the arrow points. Bad sleep making everything else worse is entirely plausible, and so is everything else being bad enough to wreck your sleep. In practice it’s very probably both, feeding each other, which is the least satisfying answer and usually the correct one.

It’s worth saying how poor that quality of life picture actually is, as it tends to get softened in summaries. Compared against the general population matched for age and sex, health related quality of life in POTS sits a long way down [9], and the self reported symptom burden across this condition is broad rather than narrow, covering fatigue, cognitive problems, gut symptoms and pain alongside the cardiovascular ones [10]. Sleep sits in the middle of that cluster rather than off to one side of it, which is part of why treating it in isolation rarely works, and part of why it gets dismissed as a downstream detail rather than treated as a target in its own right.

The Sleep Study That Comes Back Normal

When sleep in POTS is measured objectively rather than asked about, the abnormalities are milder and considerably less consistent than the complaints are [4][5][6]. Wrist monitoring worn at home over several nights did pick up a lower proportion of time in bed actually spent asleep, along with a striking gap between how long people believed it took them to drop off and how long it genuinely took [6]. That gap is interesting in itself and we’ll come back to it.

Full overnight testing in a lab is where it gets a fair bit stranger, as a distinctive sleep disorder pattern in POTS has been looked for twice over, by separate groups, and hasn’t turned up, beyond some mild differences in the amount of REM sleep and how long it took to get there [4][5]. There’s also more light sleep and less variation in autonomic activity between the sleep stages, although that came out of a great many comparisons run in a single centre, so treat it as a lead rather than a finding [2]. And in one of them the people being compared against were already attending a sleep clinic themselves, which isn’t the same as being compared against somebody who sleeps perfectly well [5].

So, the overnight test usually looks a great deal better than the night actually felt.

That doesn’t mean nothing is wrong, and it very much doesn’t mean a normal sleep study rules the problem out [4][5]. It means the thing making your nights miserable isn’t the thing a standard sleep study was built to catch, as a sleep study is extremely good at finding breathing that stops, legs that kick, and sleep stages that are frankly deranged, and it isn’t built to measure a nervous system that stayed switched on all night while technically producing acceptable looking sleep.

Which is worth knowing before you go rather than afterwards, as a lot of people go into that test hoping for a name and come out with a normal report and the strong implication that they’ve been making a fuss. The report itself is usually accurate, it’s what gets concluded from it that’s usually wrong.

Arousal Rather Than Architecture

Put the subjective and the objective side by side and a reasonably coherent picture falls out, as the stages are roughly intact while the experience is awful, and the gap between the two is best explained by hyperarousal, which is the sleep research term for a nervous system running too hot to properly hand over [4][6][7].

In the wrist monitoring, the people who took longest to actually fall asleep were the ones with higher noradrenaline levels on standing, and the people who spent most of the night awake after initially dropping off were the ones with higher standing heart rates [6]. That’s a correlation rather than a cause, and it’s worth being clear about that, as nobody has taken a group of people with POTS, brought their standing noradrenaline down on purpose, and shown that the sleep improves as a result. What it does do, is line the bedtime problem up with the daytime physiology in a way that makes mechanistic sense, which is a reason to suspect something rather than a reason to believe it.

The wider insomnia literature has been circling much the same idea for a long time, as hyperarousal in insomnia isn’t one thing, it runs across physiological measures, brain activity during sleep, and the cognitive and emotional side of lying there with a mind that won’t shut up [7][11]. That work is in people with insomnia rather than people with POTS though, so it’s indirect. It tells you the model is well built, it doesn’t tell you the model is proven in your condition.

Going to sleep isn’t passive. It’s an active handover, where the sympathetic side of the nervous system, the part that keeps you upright and alert and moving, is supposed to hand control over to the parasympathetic side for the night. Blood pressure drops, heart rate drops, everything downshifts.

Now, if your circulation behaves badly the moment you’re vertical, then the sympathetic side of your nervous system has been doing overtime all day just to keep blood where it’s needed. That system doesn’t have a clean off switch, and a body that has been compensating hard for fourteen hours doesn’t gracefully hand over at eleven at night just because you’ve turned the lamp off. The handover is incomplete, so you get the tired but wired thing that everybody with POTS describes and almost nobody can explain to their GP.

That also explains the gap between how long you think it takes you to fall asleep and how long it actually takes [6], as lying awake in a high arousal state is a horrible way to spend twenty minutes, and it doesn’t feel like twenty minutes, it feels like an hour and a half.

That mismatch is worth handling carefully. It absolutely doesn’t mean the sleep is fine and you’re misjudging it. The perception gap turned up in the same measurements as the genuinely reduced sleep [6], so both things are true at once: the sleep is worse than it should be, and the night feels worse still. What the gap tells you, is that time spent awake in a high arousal state is being registered and stored differently from ordinary quiet wakefulness, which is exactly what you’d expect from a nervous system that hasn’t stood down.

It matters practically for two reasons. The first is that watching the clock through the night will give you a reading that’s systematically worse than what’s actually happening, which then feeds the dread the following evening, which raises the arousal, and round it goes. The second is that this loop is precisely what the cognitive part of the insomnia work is aimed at, and it’s one of the few bits of this whole area with decent evidence behind it [7]. So, turn the clock to face the wall, which is about the smallest thing anybody will ask you to do all week and costs nothing.

What Blood Pressure Does Overnight

There’s a second strand of evidence here, and it’s about what the cardiovascular system is up to while you’re asleep rather than while you’re trying to get to sleep.

Blood pressure is meant to fall overnight, and that drop, usually called dipping, is one of the more reliable signs that the autonomic handover happened properly. In children with POTS, that overnight drop happens less often than it should, and blood pressure during sleep, along with a measure of how hard the heart is working, sits higher than in matched comparison groups [12]. In a largely adult clinic group, the ones whose blood pressure failed to dip overnight, also had raised sympathetic nerve activity measured at the skin during the night, and a blunted difference between their day and their night [13].

Now, both of those need holding loosely though, as one is in children, and children with POTS aren’t small adults with POTS, and the other is in a clinic group where most people were already on treatment of one sort or another, which muddies what you can conclude about the untreated state [13]. Neither shows that non dipping is what’s ruining your sleep. What they do show, is that in at least some people with POTS, the autonomic night shift genuinely isn’t happening the way it’s supposed to, and it can be measured rather than merely felt.

That matters rather more than it sounds, as it’s the difference between a symptom nobody can see and a physiological state with measurable correlates. Your sleep study can look unremarkable while your overnight blood pressure is quietly telling a different story.

Hyperadrenergic POTS and the Wired Feeling at Bedtime

The racing mind at bedtime, the palpitations lying flat, the adrenaline surge at two in the morning that arrives with no dream attached and no explanation, these all get put down to hyperadrenergic POTS a great deal of the time, and the label is genuinely useful, it’s just softer than most people think it is.

Hyperadrenergic POTS is described in the consensus literature as a subtype where standing noradrenaline is elevated, often alongside tremor, palpitations, anxiety type symptoms, and sometimes a blood pressure that rises rather than falls on standing [14][15]. Estimates of how common it is vary a lot, because the definitions aren’t standardised and the subtypes overlap inside the same person anyway [16]. So, it’s a useful mechanism label and a fairly leaky diagnostic bucket, and both of those things are true at the same time [14][16].

For sleep specifically, the link is coherent but indirect. Within POTS, higher standing noradrenaline goes with taking longer to fall asleep [6], and outside POTS, in insomnia generally, raised noradrenaline and sympathetic activation are well established features of the physiological side of hyperarousal [17][18]. Put those together and it’s reasonable to say that hyperadrenergic physiology probably contributes to the bedtime arousal in some people with POTS. It isn’t reasonable to say it’s been demonstrated though, as direct treatment studies aimed at sleep in this specific group are basically absent [19].

Which is a shame, honestly, because it’s the single most common thing people describe and the thing with the least direct evidence behind it. The mechanism is plausible, the physiology fits, and nobody has run the study (surprise, surprise).

Sleep Apnoea, and Where It Actually Fits

You’ll find it written all over the internet that sleep apnoea is massively underdiagnosed in POTS, and applied to POTS itself that claim is too strong, as the evidence doesn’t support it.

When overnight testing in POTS has been compared against comparison groups, there’s been no clear excess of obstructive sleep apnoea [4][20]. In one of them, breathing interruptions came back at essentially the same rate as in the comparison group [4]. In another, things were mostly normal apart from mild apnoea, reduced REM and a longer wait to reach it [5], and a third look turned up a single person with apnoea and a couple with limb movements during sleep, flagged at the time as needing further evaluation rather than being treated as a pattern [2]. So, a POTS diagnosis isn’t, by itself, a reason to assume there’s undiagnosed apnoea sitting underneath it.

Hypermobility is a different question, and this is where it gets interesting for a lot of our readers. In adults with hEDS or HSD who also have obstructive sleep apnoea, the sleep is worse than in others with apnoea alone: a lower proportion of the night actually spent asleep, and more insomnia, despite the apnoea itself being no more severe and CPAP being used just as reliably [21]. And CPAP brought daytime sleepiness down in the comparison group without doing so to a meaningful degree in the hypermobile group, which suggests the leftover sleepiness in hypermobility is being driven by more than the breathing [21]. Take that with a pinch of salt though please, as chronic pain, mental health and antidepressant use couldn’t be fully accounted for, and any one of those will happily make sleep worse on its own [21].

Sleep apnoea does get listed among the recognised respiratory features of Ehlers-Danlos syndromes and hypermobility spectrum disorders, with how common it is and how best to manage it both still open questions [22].

So, don’t assume apnoea explains your POTS nights, and don’t assume it doesn’t. If you snore, if you wake gasping, if somebody has watched you stop breathing, if you get the classic morning headache, or if your sleepiness is genuinely disproportionate even by POTS standards, get tested. And if you’re hypermobile and you do get diagnosed and treated, be prepared for CPAP to fix the breathing without fixing the tiredness, as that appears to be a real pattern rather than you using the machine wrong [21].

The Gut, Mast Cell and Hormonal Overlays

POTS rarely arrives on its own, and the things that travel with it have their own effects on sleep. The trouble is that this area is drowning in confident explanation and fairly short of evidence.

What’s reasonably well established, is that the overlaps are real and common. Pooled across a large number of people with POTS, a bit under six in ten reported at least one gut symptom, and roughly a third carried a mast cell activation syndrome or joint hypermobility label [23]. Those figures come with a large asterisk though, as the groups pooled together varied enormously and a lot of the diagnoses were self reported rather than confirmed [23]. Much the same picture comes through across the gut, autonomic and immune side of hypermobile Ehlers-Danlos syndrome: the associations keep turning up, the biology connecting them is still uncertain, and diagnostic practice varies wildly between clinicians [24].

For sleep, that means something fairly specific. If your gut is what’s having you awake at two in the morning, then the sleep problem in front of you tonight is a gut problem and is worth treating as one rather than as insomnia. That’s a sensible inference rather than a demonstrated mechanism though, as nobody has shown that treating the gut symptoms in POTS improves the sleep, and it’s the sort of thing that would be straightforward enough to test if anybody ever got round to it.

Now, the hormonal side is similar. Sleep quality in women generally tends to get worse in the days before a period, and the risk of disordered breathing during sleep is higher in polycystic ovary syndrome [25][26]. Both of those are findings about women’s sleep in general rather than anything measured in POTS, so they’re a reason to expect your bad weeks to cluster rather than a POTS specific finding. Tracking it across a couple of cycles is cheap and occasionally clarifies a great deal.

What none of this supports, is treating mast cells, hypermobility or hormones as the universal explanation for POTS insomnia. The overlap is common, the mechanisms are uncertain, and the true prevalence of most of it is still unsettled [23][24][25]. Anyone selling you a single tidy cause for all of it is ahead of the evidence.

Why the Usual Sleep Advice Misses

Nearly everyone reading this has been handed the standard sleep advice at some point, and nearly everyone has found that it did very little. The reason for that is fairly specific, and worth understanding.

The standard advice is built around behaviour in the hour or two before bed. Dim the lights, no screens, no caffeine after lunch, keep the room cool, get up at the same time. All of it is sensible in the way that flossing is sensible, and none of it is aimed at the thing described above. If the arousal keeping you awake has been building all day, from a circulation that needs constant sympathetic support to stay functional [6][7], then an intervention that starts at nine in the evening is arriving at the end of a very long shift and asking politely.

There’s a more pointed version of this too. Within the insomnia treatment research, where the individual components have been separated out and compared, sleep hygiene education on its own doesn’t appear to be one of the active ingredients [27][28]. The work is carried by the harder components, the ones about time in bed and about what your bed has come to mean to you [29]. So, the advice most commonly given is the part with the least behind it, which is a slightly awkward thing for the field to have discovered and an extremely common experience for anybody who has ever tried to follow it.

Now, there’s a second reason it misses in POTS particularly, and it’s about which lever you’re pulling. Advice aimed at sleep treats the night as the problem, whereas the evidence in POTS keeps pointing at the day, as the measures that track with the bad nights are daytime and upright ones, standing heart rate and standing noradrenaline [6], and the treatment with the best direct evidence in this condition is exercise, which does nothing at all at bedtime [30][31]. That doesn’t make the evening routine worthless, it does mean that if the evening routine is the whole plan, the plan is aimed at the smaller half of the problem.

One thing to keep in mind though, the version of the advice that tells you to cut fluids in the evening sits awkwardly against everything else you’ll have been told, as increasing salt and fluid is standard management in POTS and does improve plasma volume and the orthostatic response [32]. Nobody has actually tested fluid timing against sleep outcomes in POTS in either direction [33], so if somebody gives you that instruction, it’s fair to ask what they’re basing it on before you rearrange your day around it.

What Actually Helps

Almost nothing in the POTS literature has been tested with sleep as the thing being measured. What exists is a set of treatments with decent evidence for other outcomes, a set with decent evidence for sleep in other conditions, and a gap in the middle where the studies ought to be. That gap isn’t a reason to do nothing though, it’s a reason to know which bucket each option sits in.

Exercise

Structured exercise has the strongest direct evidence in POTS of anything here, as programmes built around graded training improve aerobic fitness, exercise tolerance and some of the orthostatic symptoms [30][31][34]. The catch, and it’s a significant one, is that sleep was rarely what anybody was measuring, so the benefit to your nights is an inference from the daytime improvement rather than something that was actually tested [35][31].

Now, the inference is a reasonable one though. If the reason your nervous system won’t stand down at night is that it’s been compensating all day, then improving what your circulation does during the day is attacking the problem at the right end.

How you start matters more than what you start. The reviews are consistent that this begins horizontal or recumbent, on a rower, a recumbent bike or the floor, and progresses to upright work gradually, precisely because upright exercise is often tolerated badly early on [35][36]. And in hypermobility related POTS it needs adapting around pain, fatigue and post exertional symptoms rather than being run to a fixed protocol [34][31]. Going too hard too early is the most common way this gets abandoned, and the flare that follows gets blamed on exercise rather than on the dose.

Worth being clear about what graded actually means here, as it gets used to mean push through, which it really isn’t. It means starting at a level you can repeat the next day without paying for it, holding there until it’s genuinely easy, and only then moving up. In a condition where the symptoms swing week to week for reasons that have nothing to do with what you did in the gym, that’s harder than it sounds, as you need a plan that survives a bad fortnight without being abandoned. The programmes with the evidence behind them are structured and supervised to some degree rather than left to the person to work out alone [30][31], which is probably telling you something about how easy this is to get right unassisted.

Salt and Fluids

Salt and fluid loading is standard advice in POTS and it isn’t wrong, it’s just less settled than the confidence around it suggests. Increasing salt does improve symptoms, plasma volume and the orthostatic response [32], and both oral and intravenous strategies have a place in managing orthostatic intolerance [37]. Pooled across the orthostatic intolerance conditions though, the trial evidence is low quality and short term, with nothing looking at long term outcomes at all [33].

For sleep specifically, we’re into an evidence gap rather than a finding. Nobody has tested whether the timing of salt or fluid intake across the day changes anything about the night in POTS. Not the idea that front loading fluids helps, not the idea that stopping earlier reduces night waking, none of it. People experiment with this constantly and the community has strong opinions about it (very strong opinions, in fact), and that’s fine, but it isn’t evidence and shouldn’t be presented as any.

Getting the Head of the Bed Up

Sleeping with the whole bed tilted head up, rather than just piling up pillows, is a long standing recommendation in POTS reviews as a way of encouraging plasma volume expansion overnight [35]. It’s cheap, it’s reversible, and it’s low risk, which is honestly most of why it gets recommended.

It’s also never been properly tested in POTS, so nobody can tell you how much benefit to expect or who it works for [35]. Worth trying, with realistic expectations. And it needs to be the actual bed up on blocks or risers, rather than a stack of pillows that folds you in half at the waist.

CPAP, If You Genuinely Have Apnoea

If testing shows obstructive sleep apnoea, treat the apnoea. CPAP reduces sympathetic activation in obstructive sleep apnoea generally, and improves daytime sleepiness in typical groups [17], which given everything above about arousal is mechanistically about as sensible as this gets.

The honest caveat, again, is for the hypermobile group, where daytime sleepiness has been shown to persist despite the machine being used properly [21]. That doesn’t make CPAP pointless, as untreated apnoea is worth treating on its own terms. It does mean you should plan for the breathing and the tiredness to be two separate problems.

The Behavioural Work

Cognitive behavioural therapy for insomnia, usually shortened to CBT-I, improves insomnia severity, the proportion of time in bed spent asleep, and how long it takes to fall asleep, across a range of chronic disease groups [38][29]. That’s the best evidence base of anything in this section, by a large margin. It has just never been tested in POTS specifically, so it’s a strong finding in a related population rather than a POTS finding.

CBT-I isn’t sleep hygiene, and that’s where most advice goes wrong. The components that carry most of the benefit are sleep restriction, which means deliberately compressing your time in bed to rebuild sleep pressure, stimulus control, which means breaking the association between your bed and lying there furious, and the cognitive work on what you believe about your sleep [27][28][29]. Sleep hygiene education on its own, the darkened room and the no screens and the warm bath, doesn’t appear to be an essential active ingredient [27][28].

Which is quite the finding, given that sleep hygiene is approximately one hundred per cent of what most people with POTS have ever been offered.

One genuine word of caution though, as sleep restriction increases daytime sleepiness before it improves anything, by design, and in a condition where daytime function is already precarious that’s a real cost, and it needs doing with somebody who knows what they’re doing rather than off a worksheet you found online.

Medication, and Where Melatonin Actually Sits

No drug is approved for POTS, and the evidence behind a great deal of what gets prescribed isn’t strong [14]. That’s worth knowing before you start, not because the medications are useless, but because it sets a realistic expectation about how well studied your treatment actually is.

Melatonin comes up constantly, and a fair number of people reading this already have a box of it sitting in a drawer somewhere! In adults with chronic insomnia, the evidence for it is mixed to modest overall [39][40], and the benefit varies by age, by formulation, and quite a lot by timing [40][41]. Most people take it too late and at too high a dose, which is a formulation and timing problem rather than a melatonin problem.

There is one specific situation worth knowing about, and it’s relevant to a great many people with POTS. In adults with high blood pressure taking atenolol or metoprolol, three weeks of melatonin improved measured total sleep time, the proportion of the night spent asleep, and the time taken to fall asleep [42]. The reason is mechanistic: beta blockers suppress your own melatonin production overnight, so supplementing replaces something the medication removed. That’s a finding in people with high blood pressure rather than in POTS, so it doesn’t transfer as a treatment claim. But if you’re on a beta blocker for your POTS and your sleep got worse after starting it, that’s a conversation worth having with whoever prescribed it, as there’s a plausible mechanism sitting right there.

Putting It Together

Most people reading this have already had the lecture about screens and caffeine and have found it insulting. So, in rough order of how much sits behind each one, this is what the evidence above actually supports doing.

– Work on the daytime physiology: The strongest direct evidence in POTS is for graded exercise, and it works on the daytime physiology that’s still switched on at bedtime [30][31]. Start recumbent, progress slowly, and adapt it around pain and fatigue rather than pushing through them [35][34].

– Get the apnoea question settled properly: Not because it’s likely to be the answer in POTS, as the evidence says it usually isn’t [4][20], but because it’s the one cause here with a specific treatment, and because hypermobility does complicate the picture [21][22].

– Name the behavioural treatment you want: Ask for CBT-I, not sleep hygiene advice, and specifically the sleep restriction and stimulus control components, because those are where the benefit lives [27][28][38]. Say the acronym out loud in the appointment, it saves a fortnight.

– Take the volume strategies for what they are: Salt, fluids and getting the head of the bed up are aimed at your circulation, with reasonable short term evidence for orthostatic symptoms and effectively none for sleep outcomes [32][33][35]. If they improve your days, your nights may follow. That’s a hope with a mechanism behind it rather than a demonstrated effect.

– Look at the timing of what you already take: If you started a beta blocker and your sleep deteriorated, there’s a known mechanism for that and a plausible thing to discuss [42]. Melatonin, if it’s tried, does better at a sensible dose and a sensible hour than at a large dose at midnight [40][41].

– Track it against your cycle if you have one: Sleep quality tends to be worse premenstrually in women generally [25], so a couple of months of notes will tell you whether your worst weeks are random or scheduled.

None of that is a cure and none of it is being presented as one. What it is, is the list of things with actual reasoning attached, which puts it some distance ahead of most of what gets suggested.

What Nobody Knows Yet

The main shift in this literature over the last few years is a useful one, as POTS related sleep trouble now looks less like a single hidden sleep disorder waiting to be caught on a monitor, and more like a mix of autonomic hyperarousal, fatigue, pain and whatever else is overlapping in a given person [4][7][23].

The biggest open question is embarrassingly basic: which sleep targeted treatments actually improve sleep in well characterised groups of people with POTS. Nobody has run CBT-I in POTS and measured what happens. Nobody has tested fluid or salt timing against sleep outcomes. Nobody has looked at whether treating the hyperadrenergic side of things at night does anything for the mornings, and diet and environment as influences on sleep quality in POTS remain more or less unexamined [19]. The subgroups most likely to need separate answers, those with hypermobility, those carrying a mast cell label, those whose symptoms swing with their cycle, and those who genuinely do have apnoea, are exactly the ones nobody has studied separately.

Part of why those studies haven’t happened is that sleep keeps being treated as a downstream consequence in this condition rather than as something worth targeting directly, which is a reasonable assumption that nobody has actually checked. The other part is the phenotyping problem, as the subtype labels themselves aren’t standardised and overlap inside the same person [16][14], so recruiting a clean group to study is genuinely difficult. That isn’t an excuse, it’s a description of why this is slow, and it’s worth knowing when somebody quotes you a confident number about POTS and sleep.

So, if your sleep is dreadful and your sleep study came back clean, what you’ve been given is a test that measures a different thing from the one going wrong, rather than a clean bill of health.

The Fibro Guy


References

[1] Bagai, K., Song, Y., Ling, J.F., Malow, B., Black, B.K., Biaggioni, I. et al. (2011) ‘Sleep Disturbances and Diminished Quality of Life in Postural Tachycardia Syndrome’, Journal of Clinical Sleep Medicine. https://doi.org/10.5664/jcsm.28110

[2] Mallien, J., Isenmann, S., Mrazek, A. and Haensch, C.A. (2014) ‘Sleep Disturbances and Autonomic Dysfunction in Patients with Postural Orthostatic Tachycardia Syndrome’, Frontiers in Neurology. https://doi.org/10.3389/fneur.2014.00118

[3] Xu, X., Huang, H., Sethi, S., Zuzuárregui, J.R.P., Weinberg, J. and Hohler, A.D. (2016) ‘A survey based study on sleep disturbance in postural tachycardia syndrome’, Journal of the Neurological Sciences. https://doi.org/10.1016/j.jns.2016.04.028

Read More

[4] Bagai, K., Peltier, A.C., Malow, B.A., Diedrich, A., Shibao, C.A., Black, B.K. et al. (2016) ‘Objective Sleep Assessments in Patients with Postural Tachycardia Syndrome using Overnight Polysomnograms’, Journal of Clinical Sleep Medicine. https://doi.org/10.5664/jcsm.5806

[5] Miglis, M.G., Muppidi, S., Feakins, C., Fong, L., Prieto, T. and Jaradeh, S. (2016) ‘Sleep disorders in patients with postural tachycardia syndrome’, Clinical Autonomic Research. https://doi.org/10.1007/s10286-015-0331-9

[6] Bagai, K., Wakwe, C.I., Malow, B., Black, B.K., Biaggioni, I., Paranjape, S.Y. et al. (2013) ‘Estimation of sleep disturbances using wrist actigraphy in patients with postural tachycardia syndrome’, Autonomic Neuroscience. https://doi.org/10.1016/j.autneu.2013.02.021

[7] Dressle, R.J. and Riemann, D. (2023) ‘Hyperarousal in insomnia disorder: Current evidence and potential mechanisms’, Journal of Sleep Research. https://doi.org/10.1111/jsr.13928

[8] Pederson, C. and Blettner Brook, J. (2017) ‘Sleep disturbance linked to suicidal ideation in postural orthostatic tachycardia syndrome’, Nature and Science of Sleep. https://doi.org/10.2147/nss.s128513

[9] Seeley, M.C., Gallagher, C., Ong, E., Langdon, A., Chieng, J., Bailey, D. et al. (2023) ‘Poor health-related quality of life in postural orthostatic tachycardia syndrome in comparison with a sex- and age-matched normative population’, Clinical Autonomic Research. https://doi.org/10.1007/s10286-023-00955-9

[10] Knoop, I., Picariello, F., Jenkinson, E., Gall, N., Chisari, C. and Moss-Morris, R. (2023) ‘Self-reported symptom burden in postural orthostatic tachycardia syndrome (POTS): A narrative review of observational and interventional studies’, Autonomic Neuroscience. https://doi.org/10.1016/j.autneu.2022.103052

[11] Fernandez-Mendoza, J. (2026) ‘Mechanisms Linking Insomnia and Cardiometabolic Disease Risk’, Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.125.322880

[12] Cai, H., Wang, S., Zou, R., Wang, Y. and Wang, C. (2020) ‘Circadian rhythms of blood pressure and rate pressure product in children with postural tachycardia syndrome’, Autonomic Neuroscience. https://doi.org/10.1016/j.autneu.2020.102715

[13] Liu, X., Rosenberg, C., Reaso, J.N., Lee, A.M., Ricafrente, J., Ebinger, J.E. et al. (2023) ‘Skin sympathetic nerve activity and nocturnal blood pressure nondipping in patients with postural orthostatic tachycardia syndrome’, Journal of Hypertension. https://doi.org/10.1097/hjh.0000000000003465

[14] Vernino, S., Bourne, K.M., Stiles, L.E., Grubb, B.P., Fedorowski, A., Stewart, J.M. et al. (2021) ‘Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting – Part 1’, Autonomic Neuroscience. https://doi.org/10.1016/j.autneu.2021.102828

[15] Benarroch, E.E. (2012) ‘Postural Tachycardia Syndrome: A Heterogeneous and Multifactorial Disorder’, Mayo Clinic Proceedings. https://doi.org/10.1016/j.mayocp.2012.08.013

[16] Arnold, A.C., Ng, J. and Raj, S.R. (2018) ‘Postural tachycardia syndrome – Diagnosis, physiology, and prognosis’, Autonomic Neuroscience. https://doi.org/10.1016/j.autneu.2018.02.005

[17] Greenlund, I.M. and Carter, J.R. (2022) ‘Sympathetic neural responses to sleep disorders and insufficiencies’, American Journal of Physiology-Heart and Circulatory Physiology. https://doi.org/10.1152/ajpheart.00590.2021

[18] Bonnet, M.H. and Arand, D.L. (2010) ‘Hyperarousal and insomnia: State of the science’, Sleep Medicine Reviews. https://doi.org/10.1016/j.smrv.2009.05.002

[19] Fatima, S.S., Ayaz, S.N., Raza, A.A. and Samadi, A. (2026) ‘Diet and environment: unexplored influences on sleep quality in postural orthostatic tachycardia syndrome (POTS)’, Annals of Medicine & Surgery. https://doi.org/10.1097/ms9.0000000000005070

[20] Pengo, M.F., Higgins, S., Drakatos, P., Martin, K., Gall, N., Rossi, G.P. et al. (2015) ‘Characterisation of sleep disturbances in postural orthostatic tachycardia syndrome: a polysomnography-based study’, Sleep Medicine. https://doi.org/10.1016/j.sleep.2015.08.003

[21] Zhang, K.L., Wallon, R., Laukaitis, C.M. and Davies, C. (2026) ‘Obstructive sleep apnea and CPAP efficacy in patients with Hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder: a case-control study’, Sleep and Breathing. https://doi.org/10.1007/s11325-026-03763-3

[22] Chohan, K., Mittal, N., McGillis, L., Lopez-Hernandez, L., Camacho, E., Rachinsky, M. et al. (2021) ‘A review of respiratory manifestations and their management in Ehlers-Danlos syndromes and hypermobility spectrum disorders’, Chronic Respiratory Disease. https://doi.org/10.1177/14799731211025313

[23] Kulin, D., Shah, A., Fairlie, T., Staller, K., Nurko, S., Keefer, L. et al. (2026) ‘Gastrointestinal Symptoms and Systemic Comorbidities in Patients With POTS : A Systematic Review and Meta‐Analysis’, Neurogastroenterology & Motility. https://doi.org/10.1111/nmo.70305

[24] Aziz, Q., Harris, L.A., Goodman, B.P., Simrén, M. and Shin, A. (2025) ‘AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review’, Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2025.02.015

[25] Baker, F.C. and Lee, K.A. (2022) ‘Menstrual Cycle Effects on Sleep’, Sleep Medicine Clinics. https://doi.org/10.1016/j.jsmc.2022.02.004

[26] Haufe, A. and Leeners, B. (2023) ‘Sleep Disturbances Across a Woman’s Lifespan: What Is the Role of Reproductive Hormones?’, Journal of the Endocrine Society. https://doi.org/10.1210/jendso/bvad036

[27] Furukawa, Y., Sakata, M., Yamamoto, R., Nakajima, S., Kikuchi, S., Inoue, M. et al. (2024) ‘Components and Delivery Formats of Cognitive Behavioral Therapy for Chronic Insomnia in Adults’, JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2023.5060

[28] Steinmetz, L., Simon, L., Feige, B., Riemann, D., Johann, A.F., Ell, J. et al. (2024) ‘Network meta-analysis examining efficacy of components of cognitive behavioural therapy for insomnia’, Clinical Psychology Review. https://doi.org/10.1016/j.cpr.2024.102507

[29] Walker, J., Muench, A., Perlis, M.L. and Vargas, I. (2022) ‘Cognitive Behavioral Therapy for Insomnia (CBT-I): A Primer’, Clinical Psychology and Special Education. https://doi.org/10.17759/cpse.2022110208

[30] Wheatley-Guy, C.M., Shea, M.G., Parks, J.K., Scales, R., Goodman, B.P., Butterfield, R.J. et al. (2023) ‘Semi-supervised exercise training program more effective for individuals with postural orthostatic tachycardia syndrome in randomized controlled trial’, Clinical Autonomic Research. https://doi.org/10.1007/s10286-023-00970-w

[31] Cortez, M.M., Aikins, K., Arnold, A.C., Boris, J.R., Davenport, T.E., Johnson, K. et al. (2025) ‘Impact of exercise to treat postural orthostatic tachycardia syndrome: a systematic review’, Frontiers in Neurology. https://doi.org/10.3389/fneur.2025.1567708

[32] Williams, E.L., Raj, S.R., Schondorf, R., Shen, W.K., Wieling, W. and Claydon, V.E. (2022) ‘Salt supplementation in the management of orthostatic intolerance: Vasovagal syncope and postural orthostatic tachycardia syndrome’, Autonomic Neuroscience. https://doi.org/10.1016/j.autneu.2021.102906

[33] Loughlin, E.A., Judge, C.S., Gorey, S.E., Costello, M.M., Murphy, R.P., Waters, R.F. et al. (2020) ‘Increased Salt Intake for Orthostatic Intolerance Syndromes: A Systematic Review and Meta-Analysis’, The American Journal of Medicine. https://doi.org/10.1016/j.amjmed.2020.05.028

[34] Peebles, K.C., Jacobs, C., Makaroff, L. and Pacey, V. (2024) ‘The use and effectiveness of exercise for managing postural orthostatic tachycardia syndrome in young adults with joint hypermobility and related conditions: A scoping review’, Autonomic Neuroscience. https://doi.org/10.1016/j.autneu.2024.103156

[35] Fu, Q. and Levine, B.D. (2018) ‘Exercise and non-pharmacological treatment of POTS’, Autonomic Neuroscience. https://doi.org/10.1016/j.autneu.2018.07.001

[36] Gonçalves Leite Rocco, P., Reategui-Rivera, C.M. and Finkelstein, J. (2024) ‘Exercise Interventions in the Management of Postural Orthostatic Tachycardia Syndrome: A Scoping Review’, Journal of Multidisciplinary Healthcare. https://doi.org/10.2147/jmdh.s495088

[37] Snapper, H. and Cheshire, W.P. (2022) ‘Oral and intravenous hydration in the treatment of orthostatic hypotension and postural tachycardia syndrome’, Autonomic Neuroscience. https://doi.org/10.1016/j.autneu.2022.102951

[38] Scott, A.J., Correa, A.B., Bisby, M.A., Chandra, S.S., Rahimi, M., Christina, S. et al. (2025) ‘Cognitive Behavioral Therapy for Insomnia in People With Chronic Disease’, JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2025.4610

[39] Choi, K., Lee, Y.J., Park, S., Je, N.K. and Suh, H.S. (2022) ‘Efficacy of melatonin for chronic insomnia: Systematic reviews and meta-analyses’, Sleep Medicine Reviews. https://doi.org/10.1016/j.smrv.2022.101692

[40] Maruani, J., Reynaud, E., Chambe, J., Palagini, L., Bourgin, P. and Geoffroy, P.A. (2023) ‘Efficacy of melatonin and ramelteon for the acute and long‐term management of insomnia disorder in adults: A systematic review and meta‐analysis’, Journal of Sleep Research. https://doi.org/10.1111/jsr.13939

[41] Cruz‐Sanabria, F., Bruno, S., Crippa, A., Frumento, P., Scarselli, M., Skene, D.J. et al. (2024) ‘Optimizing the Time and Dose of Melatonin as a Sleep‐Promoting Drug: A Systematic Review of Randomized Controlled Trials and Dose−Response Meta‐Analysis’, Journal of Pineal Research. https://doi.org/10.1111/jpi.12985

[42] Scheer, F.A.J.L., Morris, C.J., Garcia, J.I., Smales, C., Kelly, E.E., Marks, J. et al. (2012) ‘Repeated Melatonin Supplementation Improves Sleep in Hypertensive Patients Treated with Beta-Blockers: A Randomized Controlled Trial’, Sleep. https://doi.org/10.5665/sleep.2122